Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Tramonti, Gianfranco
Xie, Ping
Wallner, Elisabeth I.
Danesh, Farhad R.
and
Kanwar, Yashpal S.
2006.
Expression and functional characteristics of tubular transporters: P-glycoprotein, PEPT1, and PEPT2 in renal mass reduction and diabetes.
American Journal of Physiology-Renal Physiology,
Vol. 291,
Issue. 5,
p.
F972.
Ricci, Carlo
Iacobini, Carla
Oddi, Giovanna
Amadio, Lorena
Menini, Stefano
Rastaldi, Maria Pia
Frasheri, Aurora
Pricci, Flavia
Pugliese, Francesco
and
Pugliese, Giuseppe
2006.
Role of TGF-β/GLUT1 axis in susceptibility vs resistance to diabetic glomerulopathy in the Milan rat model.
Nephrology Dialysis Transplantation,
Vol. 21,
Issue. 6,
p.
1514.
Bloomgarden, Zachary T.
2008.
Diabetic Nephropathy.
Diabetes Care,
Vol. 31,
Issue. 4,
p.
823.
Zhang, Hongyu
Saha, Jharna
Byun, Jaeman
Schin, MaryLee
Lorenz, Matthew
Kennedy, Robert T.
Kretzler, Matthias
Feldman, Eva L.
Pennathur, Subramaniam
and
Brosius, Frank C.
2008.
Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.
American Journal of Physiology-Renal Physiology,
Vol. 295,
Issue. 4,
p.
F1071.
Buller, Carolyn L.
Loberg, Robert D.
Fan, Ming-Hui
Zhu, Qihong
Park, James L.
Vesely, Eileen
Inoki, Ken
Guan, Kun-Liang
and
Brosius, Frank C.
2008.
A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression.
American Journal of Physiology-Cell Physiology,
Vol. 295,
Issue. 3,
p.
C836.
Makni, K
Jarraya, F
Rebaï, M
Mnif, F
Boudawara, M
Hamza, N
Rekik, N
Abid, M
Hachicha, J
Granier, C
Rebaï, A
Ayadi, H
Makni, K
Jarraya, F
Rebaï, M
Mnif, F
Boudawara, M
Hamza, N
Rekik, N
Abid, M
Hachicha, J
Granier, C
Rebaï, A
and
Ayadi, H
2008.
Risk genotypes and haplotypes of the GLUT1 gene for type 2 diabetic nephropathy in the Tunisian population.
Annals of Human Biology,
Vol. 35,
Issue. 5,
p.
490.
Kasahara, Emiko
Kashiba, Misato
Jikumaru, Mika
Kuratsune, Daisuke
Orita, Kumi
Yamate, Yurika
Hara, Kenjiro
Sekiyama, Atsuo
Sato, Eisuke F.
and
Inoue, Masayasu
2009.
Dynamic aspects of ascorbic acid metabolism in the circulation: analysis by ascorbate oxidase with a prolonged in vivo half-life.
Biochemical Journal,
Vol. 421,
Issue. 2,
p.
293.
Brosius, Frank C.
Alpers, Charles E.
Bottinger, Erwin P.
Breyer, Matthew D.
Coffman, Thomas M.
Gurley, Susan B.
Harris, Raymond C.
Kakoki, Masao
Kretzler, Matthias
Leiter, Edward H.
Levi, Moshe
McIndoe, Richard A.
Sharma, Kumar
Smithies, Oliver
Susztak, Katalin
Takahashi, Nobuyuki
and
Takahashi, Takamune
2009.
Mouse Models of Diabetic Nephropathy.
Journal of the American Society of Nephrology,
Vol. 20,
Issue. 12,
p.
2503.
Lewko, Barbara
and
Stepinski, Jan
2009.
Hyperglycemia and mechanical stress: Targeting the renal podocyte.
Journal of Cellular Physiology,
Vol. 221,
Issue. 2,
p.
288.
Wang, Youli
Heilig, Kathleen O
Minto, Andrew W
Chen, Shenglin
Xiang, Minghui
Dean, David A
Geiger, Richard C
Chang, Anthony
Pravtcheva, Dimitrina D
Schlimme, Martin
Deb, Dilip K
Wang, Ying
and
Heilig, Charles W
2010.
Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF.
Laboratory Investigation,
Vol. 90,
Issue. 1,
p.
83.
Zhang, Hongyu
Schin, MaryLee
Saha, Jharna
Burke, Kathleen
Holzman, Lawrence B.
Filipiak, Wanda
Saunders, Thomas
Xiang, Minghui
Heilig, Charles W.
and
Brosius, Frank C.
2010.
Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.
American Journal of Physiology-Renal Physiology,
Vol. 299,
Issue. 1,
p.
F91.
Dabla, Pradeep Kumar
2010.
Renal function in diabetic nephropathy.
World Journal of Diabetes,
Vol. 1,
Issue. 2,
p.
48.
Stratta, Piero
Gravellone, Luciana
Cena, Tiziana
Rossi, Davide
Gaidano, GianLuca
Fenoglio, Roberta
Lazzarich, Elisa
Quaglia, Marco
Airoldi, Andrea
Bozzola, Cristina
Monga, Guido
Valente, Guido
Canavese, Caterina
and
Magnani, Corrado
2011.
Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: A single center experience.
Critical Reviews in Oncology/Hematology,
Vol. 79,
Issue. 1,
p.
31.
Buller, Carolyn L.
Heilig, Charles W.
and
Brosius, Frank C.
2011.
GLUT1 enhances mTOR activity independently of TSC2 and AMPK.
American Journal of Physiology-Renal Physiology,
Vol. 301,
Issue. 3,
p.
F588.
Mather, Amanda
and
Pollock, Carol
2011.
Glucose handling by the kidney.
Kidney International,
Vol. 79,
Issue. ,
p.
S1.
Hsu, Charles C
Kao, Wenhong L
Steffes, Michael W
Gambir, Tejal
Brancati, Frederick L
Heilig, Charles W
Shuldiner, Alan R
Boerwinkle, Eric A
and
Coresh, Josef
2011.
Genetic variation of Glucose Transporter-1 (GLUT1) and albuminuria in 10,278 European Americans and African Americans: a case-control study in the Atherosclerosis Risk in Communities (ARIC) Study.
BMC Medical Genetics,
Vol. 12,
Issue. 1,
Wu, Fiona
Satchwell, Timothy J.
and
Toye, Ashley M.
2011.
Anion exchanger 1 in red blood cells and kidney: Band 3’s in a podThis paper is one of a selection of papers published in a Special Issue entitled CSBMCB 53rd Annual Meeting — Membrane Proteins in Health and Disease, and has undergone the Journal’s usual peer review process..
Biochemistry and Cell Biology,
Vol. 89,
Issue. 2,
p.
106.
Dey, Nirmalya
Das, Falguni
Mariappan, Meenalakshmi M.
Mandal, Chandi Charan
Ghosh-Choudhury, Nandini
Kasinath, Balakuntalam S.
and
Choudhury, Goutam Ghosh
2011.
MicroRNA-21 Orchestrates High Glucose-induced Signals to TOR Complex 1, Resulting in Renal Cell Pathology in Diabetes.
Journal of Biological Chemistry,
Vol. 286,
Issue. 29,
p.
25586.
Hymavati
Kumar, Vivek
and
Elizabeth Sobhia, M.
2012.
Implication of Crystal Water Molecules in Inhibitor Binding at ALR2 Active Site.
Computational and Mathematical Methods in Medicine,
Vol. 2012,
Issue. ,
p.
1.
da Silva, Ariel S.
Dias, Lucinara D.
Borges, Júlia F.
Markoski, Melissa M.
de Souza, Martina S.
Irigoyen, Maria C.
Machado, Ubiratan F.
and
Schaan, Beatriz D.
2013.
Renal GLUT1 reduction depends on angiotensin-converting enzyme inhibition in diabetic hypertensive rats.
Life Sciences,
Vol. 92,
Issue. 24-26,
p.
1174.